No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group
Year: 2020
Type: article
Study design: Clinical Trial
Authors: Thoralf Lange, Christian Niederwieser, Arthur Gil, Rainer Krahl, Ulrich von Grünhagen, Haifa Kathrin Al-Ali, Kathleen Jentsch-Ullrich, Claudia Spohn, Volker Lakner, Michael Assmann, Christian Junghanss, Michael Cross, Rüdiger Hehlmann, Michael Deininger, Markus Pfirrmann, Dietger Niederwieser
Institutions: Asklepios Klinik Weißenfels, Leipzig University, University Medical Center Hamburg-Eppendorf, Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, University Hospital in Halle, Elblandklinikum Riesa, Universitätsmedizin Rostock, University of Rostock, Heidelberg University, University of Utah, Huntsman Cancer Institute, Lithuanian University of Health Sciences, Aichi Medical University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3043548980